Erick Suazo-Zepeda

5PUBLICATIONS

13CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPreventative health care

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 28, 2026

The Association and Predictive Value of Nutritional and Inflammatory Biomarkers in Advanced Non-Small Cell Lung Cancer Response to Immune Checkpoint Inhibitors.

|Apr 17, 2026

Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-analysis.

|Mar 11, 2026

Association of CT-assessed sarcopenia and the development of immune-related adverse events and overall survival: a multistate survival analysis.

Erick Suazo-Zepeda, Marjolein A Heuvelmans, Douwe Postmus

|Oct 21, 2024

Trends in the prescription of immune checkpoint inhibitors for non-small cell lung cancer in the Netherlands from 2016 to 2020, a national cancer registry analysis.

Erick Suazo-Zepeda, Willemijn J Maas, Petra C Vinke

|Jun 22, 2022

Reduction in the Treatment Gap for Breast Cancer in Mexico under Seguro Popular, 2007 to 2016.

Karla Unger-Saldaña, Alejandra Contreras-Manzano, Héctor Lamadrid-Figueroa

Pageof 1

Frequent Collaborators

3 joint publications

T Jeroen N Hiltermann

3 joint publications

Geertruida H de Bock

2 joint publications

Marjolein A Heuvelmans

1 joint publications

Karla Unger-Saldaña

1 joint publications

Alejandra Contreras-Manzano

1 joint publications

Héctor Lamadrid-Figueroa

1 joint publications

Alejandro Mohar

1 joint publications

Priscilla Espinosa-Tamez

1 joint publications

Martin Lajous

1 joint publications

Michael R Reich

Frequent Collaborators

3 joint publications

T Jeroen N Hiltermann

3 joint publications

Geertruida H de Bock

2 joint publications

Marjolein A Heuvelmans

1 joint publications

Karla Unger-Saldaña